Esophagus squamous cell papilloma

Summary

Esophagus squamous cell papilloma (MONDO:0004827) is a disease. A subtype of squamous papilloma — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	esophagus squamous cell papilloma
Mondo ID	MONDO:0004827
DOID	DOID:959
ICD-11	1028052947
NCIT	C5344
UMLS	C1333467
MedGen	272592
Anatomy (UBERON)	UBERON:0001043
Is cancer (heuristic)	no

Also known as: esophageal squamous papilloma · esophagus squamous cell papilloma · esophagus squamous papilloma · oesophagus squamous papilloma · squamous cell papilloma of esophagus · squamous cell papilloma of oesophagus · squamous cell papilloma of the esophagus · squamous cell papilloma of the oesophagus

Disease family

This is a subtype of squamous papilloma. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › epithelial neoplasm › papillary epithelial neoplasm › papilloma › squamous papilloma › esophagus squamous cell papilloma

Related subtypes (7): larynx squamous papilloma, bladder squamous papilloma, vaginal squamous papilloma, vestibular papilloma, nasal vestibule squamous papilloma, squamous cell skin papilloma, cervix squamous papilloma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.